Insider Trading Activity For EyeGate Pharma (NASDAQ:EYEG)
Armistice Capital Master Fund , Major Shareholder of EyeGate Pharma (NASDAQ:EYEG) reportedly Bought 10,479,970 shares of the company’s stock at an average price of 0.36 for a total transaction amount of $3,772,789.20 SEC Form
Insider Trading History For EyeGate Pharma (NASDAQ:EYEG)
Analyst Ratings History For EyeGate Pharma (NASDAQ:EYEG)
- On 6/28/2016 Maxim Group Reiterated Rating Hold
- On 12/1/2016 Rodman & Renshaw Reiterated Rating Buy with a price target of $10.00
- On 12/6/2016 Chardan Capital Reiterated Rating Buy with a price target of $6.00
- On 5/19/2017 Noble Financial Reiterated Rating Buy
- On 3/11/2018 HC Wainwright Set Price Target of rating Buy with a price target of $3.00
Recent Trading Activity for EyeGate Pharma (NASDAQ:EYEG)
Shares of EyeGate Pharma closed the previous trading session at with 0.421099990606308 shares trading hands.